Baidu
map
INFECT AGENTS CANCER 润色咨询

Infectious Agents and Cancer

出版年份：暂无数据 年文章数：483 投稿命中率： 开通期刊会员，数据随心看

出版周期：Irregular 自引率：5.8% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2235145, encodeId=b60d22351454a, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：HHV8;Burkitt lymphoma;EBV<br>经验分享：编辑和审稿人都非常友好，投稿5周无回复，发邮件问了一下，1周后小修，之后4周顺利发表，前后用时12周左右，是我发表文章最顺利的一次，衷心感谢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=31938185260, createdName=ms9000001702333969, createdTime=Mon Nov 04 20:35:15 CST 2024, time=2024-11-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=894038, encodeId=6d2389403809, content=审稿速度:2.0 | 投稿命中率:95.0<br>经验分享：从投稿到接收2个月，中间两次大修, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24e71740290, createdName=changer11, createdTime=Fri Oct 23 23:55:35 CST 2020, time=2020-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2123578, encodeId=d41521235e840, content=投稿2个月了，还没找到审稿人，好慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f215550116, createdName=ms8000000387487195, createdTime=Mon Apr 03 23:17:10 CST 2023, time=2023-04-03, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1105501, encodeId=8fd8110550150, content=关键词最少几个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105502, encodeId=c8b2110550242, content=一般期刊要求关键词有多少个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601201, encodeId=2c11601201f3, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:2380.0<br>偏重的研究方向：病毒;肿瘤;感染<br>经验分享：编辑很友好，每次发邮件询问都很快回复，并及时将我的疑问转达给审稿人。审稿人很负责，认真回答我的问题。2月初投稿，4月28接收。大修1次，小修1次。现在proof。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220130/d287bef646804051826c653c20ade5c5/3189bee4394c4a70a2c21f4e2d6b8f13.jpg, createdBy=cb882558554, createdName=cmj544, createdTime=Tue Jun 02 17:50:51 CST 2020, time=2020-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574295, encodeId=e0d75e4295b2, content=还没投出去呢，不知道为什么，一直说我未授权, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIJiaCLWwZ60RaAUTVZeItKTcsUicNPFHRB64Bo60Rk8ICbaZCX5YcWrz5kgZqEH8UiaxuECuUufYmZg/132, createdBy=01cb2245548, createdName=呦呦517383645, createdTime=Thu Aug 01 22:01:00 CST 2019, time=2019-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846924, encodeId=40f584692407, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：比较一般的期刊吧，不过还是可以考虑一下的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c09a5414026, createdName=ms4662714744603927, createdTime=Mon Sep 03 15:50:22 CST 2018, time=2018-09-03, status=1, ipAttribution=)]
    2024-11-04 ms9000001702333969 来自北京

    审稿速度:2.0 | 投稿命中率:50.0
    偏重的研究方向：HHV8;Burkitt lymphoma;EBV
    经验分享：编辑和审稿人都非常友好，投稿5周无回复，发邮件问了一下，1周后小修，之后4周顺利发表，前后用时12周左右，是我发表文章最顺利的一次，衷心感谢。

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2235145, encodeId=b60d22351454a, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：HHV8;Burkitt lymphoma;EBV<br>经验分享：编辑和审稿人都非常友好，投稿5周无回复，发邮件问了一下，1周后小修，之后4周顺利发表，前后用时12周左右，是我发表文章最顺利的一次，衷心感谢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=31938185260, createdName=ms9000001702333969, createdTime=Mon Nov 04 20:35:15 CST 2024, time=2024-11-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=894038, encodeId=6d2389403809, content=审稿速度:2.0 | 投稿命中率:95.0<br>经验分享：从投稿到接收2个月，中间两次大修, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24e71740290, createdName=changer11, createdTime=Fri Oct 23 23:55:35 CST 2020, time=2020-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2123578, encodeId=d41521235e840, content=投稿2个月了，还没找到审稿人，好慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f215550116, createdName=ms8000000387487195, createdTime=Mon Apr 03 23:17:10 CST 2023, time=2023-04-03, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1105501, encodeId=8fd8110550150, content=关键词最少几个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105502, encodeId=c8b2110550242, content=一般期刊要求关键词有多少个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601201, encodeId=2c11601201f3, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:2380.0<br>偏重的研究方向：病毒;肿瘤;感染<br>经验分享：编辑很友好，每次发邮件询问都很快回复，并及时将我的疑问转达给审稿人。审稿人很负责，认真回答我的问题。2月初投稿，4月28接收。大修1次，小修1次。现在proof。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220130/d287bef646804051826c653c20ade5c5/3189bee4394c4a70a2c21f4e2d6b8f13.jpg, createdBy=cb882558554, createdName=cmj544, createdTime=Tue Jun 02 17:50:51 CST 2020, time=2020-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574295, encodeId=e0d75e4295b2, content=还没投出去呢，不知道为什么，一直说我未授权, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIJiaCLWwZ60RaAUTVZeItKTcsUicNPFHRB64Bo60Rk8ICbaZCX5YcWrz5kgZqEH8UiaxuECuUufYmZg/132, createdBy=01cb2245548, createdName=呦呦517383645, createdTime=Thu Aug 01 22:01:00 CST 2019, time=2019-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846924, encodeId=40f584692407, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：比较一般的期刊吧，不过还是可以考虑一下的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c09a5414026, createdName=ms4662714744603927, createdTime=Mon Sep 03 15:50:22 CST 2018, time=2018-09-03, status=1, ipAttribution=)]
    2020-10-23 changer11

    审稿速度:2.0 | 投稿命中率:95.0
    经验分享：从投稿到接收2个月，中间两次大修

    3

    展开3条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2235145, encodeId=b60d22351454a, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：HHV8;Burkitt lymphoma;EBV<br>经验分享：编辑和审稿人都非常友好，投稿5周无回复，发邮件问了一下，1周后小修，之后4周顺利发表，前后用时12周左右，是我发表文章最顺利的一次，衷心感谢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=31938185260, createdName=ms9000001702333969, createdTime=Mon Nov 04 20:35:15 CST 2024, time=2024-11-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=894038, encodeId=6d2389403809, content=审稿速度:2.0 | 投稿命中率:95.0<br>经验分享：从投稿到接收2个月，中间两次大修, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24e71740290, createdName=changer11, createdTime=Fri Oct 23 23:55:35 CST 2020, time=2020-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2123578, encodeId=d41521235e840, content=投稿2个月了，还没找到审稿人，好慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f215550116, createdName=ms8000000387487195, createdTime=Mon Apr 03 23:17:10 CST 2023, time=2023-04-03, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1105501, encodeId=8fd8110550150, content=关键词最少几个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105502, encodeId=c8b2110550242, content=一般期刊要求关键词有多少个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601201, encodeId=2c11601201f3, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:2380.0<br>偏重的研究方向：病毒;肿瘤;感染<br>经验分享：编辑很友好，每次发邮件询问都很快回复，并及时将我的疑问转达给审稿人。审稿人很负责，认真回答我的问题。2月初投稿，4月28接收。大修1次，小修1次。现在proof。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220130/d287bef646804051826c653c20ade5c5/3189bee4394c4a70a2c21f4e2d6b8f13.jpg, createdBy=cb882558554, createdName=cmj544, createdTime=Tue Jun 02 17:50:51 CST 2020, time=2020-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574295, encodeId=e0d75e4295b2, content=还没投出去呢，不知道为什么，一直说我未授权, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIJiaCLWwZ60RaAUTVZeItKTcsUicNPFHRB64Bo60Rk8ICbaZCX5YcWrz5kgZqEH8UiaxuECuUufYmZg/132, createdBy=01cb2245548, createdName=呦呦517383645, createdTime=Thu Aug 01 22:01:00 CST 2019, time=2019-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846924, encodeId=40f584692407, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：比较一般的期刊吧，不过还是可以考虑一下的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c09a5414026, createdName=ms4662714744603927, createdTime=Mon Sep 03 15:50:22 CST 2018, time=2018-09-03, status=1, ipAttribution=)]
    2023-04-03 ms8000000387487195 来自山东省

    投稿2个月了，还没找到审稿人，好慢啊

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2235145, encodeId=b60d22351454a, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：HHV8;Burkitt lymphoma;EBV<br>经验分享：编辑和审稿人都非常友好，投稿5周无回复，发邮件问了一下，1周后小修，之后4周顺利发表，前后用时12周左右，是我发表文章最顺利的一次，衷心感谢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=31938185260, createdName=ms9000001702333969, createdTime=Mon Nov 04 20:35:15 CST 2024, time=2024-11-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=894038, encodeId=6d2389403809, content=审稿速度:2.0 | 投稿命中率:95.0<br>经验分享：从投稿到接收2个月，中间两次大修, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24e71740290, createdName=changer11, createdTime=Fri Oct 23 23:55:35 CST 2020, time=2020-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2123578, encodeId=d41521235e840, content=投稿2个月了，还没找到审稿人，好慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f215550116, createdName=ms8000000387487195, createdTime=Mon Apr 03 23:17:10 CST 2023, time=2023-04-03, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1105501, encodeId=8fd8110550150, content=关键词最少几个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105502, encodeId=c8b2110550242, content=一般期刊要求关键词有多少个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601201, encodeId=2c11601201f3, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:2380.0<br>偏重的研究方向：病毒;肿瘤;感染<br>经验分享：编辑很友好，每次发邮件询问都很快回复，并及时将我的疑问转达给审稿人。审稿人很负责，认真回答我的问题。2月初投稿，4月28接收。大修1次，小修1次。现在proof。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220130/d287bef646804051826c653c20ade5c5/3189bee4394c4a70a2c21f4e2d6b8f13.jpg, createdBy=cb882558554, createdName=cmj544, createdTime=Tue Jun 02 17:50:51 CST 2020, time=2020-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574295, encodeId=e0d75e4295b2, content=还没投出去呢，不知道为什么，一直说我未授权, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIJiaCLWwZ60RaAUTVZeItKTcsUicNPFHRB64Bo60Rk8ICbaZCX5YcWrz5kgZqEH8UiaxuECuUufYmZg/132, createdBy=01cb2245548, createdName=呦呦517383645, createdTime=Thu Aug 01 22:01:00 CST 2019, time=2019-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846924, encodeId=40f584692407, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：比较一般的期刊吧，不过还是可以考虑一下的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c09a5414026, createdName=ms4662714744603927, createdTime=Mon Sep 03 15:50:22 CST 2018, time=2018-09-03, status=1, ipAttribution=)]
    2021-12-27 MS68862005

    关键词最少几个？

    1

    展开1条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2235145, encodeId=b60d22351454a, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：HHV8;Burkitt lymphoma;EBV<br>经验分享：编辑和审稿人都非常友好，投稿5周无回复，发邮件问了一下，1周后小修，之后4周顺利发表，前后用时12周左右，是我发表文章最顺利的一次，衷心感谢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=31938185260, createdName=ms9000001702333969, createdTime=Mon Nov 04 20:35:15 CST 2024, time=2024-11-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=894038, encodeId=6d2389403809, content=审稿速度:2.0 | 投稿命中率:95.0<br>经验分享：从投稿到接收2个月，中间两次大修, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24e71740290, createdName=changer11, createdTime=Fri Oct 23 23:55:35 CST 2020, time=2020-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2123578, encodeId=d41521235e840, content=投稿2个月了，还没找到审稿人，好慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f215550116, createdName=ms8000000387487195, createdTime=Mon Apr 03 23:17:10 CST 2023, time=2023-04-03, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1105501, encodeId=8fd8110550150, content=关键词最少几个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105502, encodeId=c8b2110550242, content=一般期刊要求关键词有多少个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601201, encodeId=2c11601201f3, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:2380.0<br>偏重的研究方向：病毒;肿瘤;感染<br>经验分享：编辑很友好，每次发邮件询问都很快回复，并及时将我的疑问转达给审稿人。审稿人很负责，认真回答我的问题。2月初投稿，4月28接收。大修1次，小修1次。现在proof。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220130/d287bef646804051826c653c20ade5c5/3189bee4394c4a70a2c21f4e2d6b8f13.jpg, createdBy=cb882558554, createdName=cmj544, createdTime=Tue Jun 02 17:50:51 CST 2020, time=2020-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574295, encodeId=e0d75e4295b2, content=还没投出去呢，不知道为什么，一直说我未授权, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIJiaCLWwZ60RaAUTVZeItKTcsUicNPFHRB64Bo60Rk8ICbaZCX5YcWrz5kgZqEH8UiaxuECuUufYmZg/132, createdBy=01cb2245548, createdName=呦呦517383645, createdTime=Thu Aug 01 22:01:00 CST 2019, time=2019-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846924, encodeId=40f584692407, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：比较一般的期刊吧，不过还是可以考虑一下的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c09a5414026, createdName=ms4662714744603927, createdTime=Mon Sep 03 15:50:22 CST 2018, time=2018-09-03, status=1, ipAttribution=)]
    2021-12-27 Gym璨烨

    一般期刊要求关键词有多少个？

    1

    展开1条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2235145, encodeId=b60d22351454a, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：HHV8;Burkitt lymphoma;EBV<br>经验分享：编辑和审稿人都非常友好，投稿5周无回复，发邮件问了一下，1周后小修，之后4周顺利发表，前后用时12周左右，是我发表文章最顺利的一次，衷心感谢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=31938185260, createdName=ms9000001702333969, createdTime=Mon Nov 04 20:35:15 CST 2024, time=2024-11-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=894038, encodeId=6d2389403809, content=审稿速度:2.0 | 投稿命中率:95.0<br>经验分享：从投稿到接收2个月，中间两次大修, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24e71740290, createdName=changer11, createdTime=Fri Oct 23 23:55:35 CST 2020, time=2020-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2123578, encodeId=d41521235e840, content=投稿2个月了，还没找到审稿人，好慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f215550116, createdName=ms8000000387487195, createdTime=Mon Apr 03 23:17:10 CST 2023, time=2023-04-03, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1105501, encodeId=8fd8110550150, content=关键词最少几个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105502, encodeId=c8b2110550242, content=一般期刊要求关键词有多少个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601201, encodeId=2c11601201f3, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:2380.0<br>偏重的研究方向：病毒;肿瘤;感染<br>经验分享：编辑很友好，每次发邮件询问都很快回复，并及时将我的疑问转达给审稿人。审稿人很负责，认真回答我的问题。2月初投稿，4月28接收。大修1次，小修1次。现在proof。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220130/d287bef646804051826c653c20ade5c5/3189bee4394c4a70a2c21f4e2d6b8f13.jpg, createdBy=cb882558554, createdName=cmj544, createdTime=Tue Jun 02 17:50:51 CST 2020, time=2020-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574295, encodeId=e0d75e4295b2, content=还没投出去呢，不知道为什么，一直说我未授权, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIJiaCLWwZ60RaAUTVZeItKTcsUicNPFHRB64Bo60Rk8ICbaZCX5YcWrz5kgZqEH8UiaxuECuUufYmZg/132, createdBy=01cb2245548, createdName=呦呦517383645, createdTime=Thu Aug 01 22:01:00 CST 2019, time=2019-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846924, encodeId=40f584692407, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：比较一般的期刊吧，不过还是可以考虑一下的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c09a5414026, createdName=ms4662714744603927, createdTime=Mon Sep 03 15:50:22 CST 2018, time=2018-09-03, status=1, ipAttribution=)]
    2020-06-02 cmj544

    审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:2380.0
    偏重的研究方向：病毒;肿瘤;感染
    经验分享：编辑很友好，每次发邮件询问都很快回复，并及时将我的疑问转达给审稿人。审稿人很负责，认真回答我的问题。2月初投稿，4月28接收。大修1次，小修1次。现在proof。

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2235145, encodeId=b60d22351454a, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：HHV8;Burkitt lymphoma;EBV<br>经验分享：编辑和审稿人都非常友好，投稿5周无回复，发邮件问了一下，1周后小修，之后4周顺利发表，前后用时12周左右，是我发表文章最顺利的一次，衷心感谢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=31938185260, createdName=ms9000001702333969, createdTime=Mon Nov 04 20:35:15 CST 2024, time=2024-11-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=894038, encodeId=6d2389403809, content=审稿速度:2.0 | 投稿命中率:95.0<br>经验分享：从投稿到接收2个月，中间两次大修, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24e71740290, createdName=changer11, createdTime=Fri Oct 23 23:55:35 CST 2020, time=2020-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2123578, encodeId=d41521235e840, content=投稿2个月了，还没找到审稿人，好慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f215550116, createdName=ms8000000387487195, createdTime=Mon Apr 03 23:17:10 CST 2023, time=2023-04-03, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1105501, encodeId=8fd8110550150, content=关键词最少几个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105502, encodeId=c8b2110550242, content=一般期刊要求关键词有多少个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601201, encodeId=2c11601201f3, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:2380.0<br>偏重的研究方向：病毒;肿瘤;感染<br>经验分享：编辑很友好，每次发邮件询问都很快回复，并及时将我的疑问转达给审稿人。审稿人很负责，认真回答我的问题。2月初投稿，4月28接收。大修1次，小修1次。现在proof。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220130/d287bef646804051826c653c20ade5c5/3189bee4394c4a70a2c21f4e2d6b8f13.jpg, createdBy=cb882558554, createdName=cmj544, createdTime=Tue Jun 02 17:50:51 CST 2020, time=2020-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574295, encodeId=e0d75e4295b2, content=还没投出去呢，不知道为什么，一直说我未授权, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIJiaCLWwZ60RaAUTVZeItKTcsUicNPFHRB64Bo60Rk8ICbaZCX5YcWrz5kgZqEH8UiaxuECuUufYmZg/132, createdBy=01cb2245548, createdName=呦呦517383645, createdTime=Thu Aug 01 22:01:00 CST 2019, time=2019-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846924, encodeId=40f584692407, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：比较一般的期刊吧，不过还是可以考虑一下的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c09a5414026, createdName=ms4662714744603927, createdTime=Mon Sep 03 15:50:22 CST 2018, time=2018-09-03, status=1, ipAttribution=)]
    2019-08-01 呦呦517383645

    还没投出去呢，不知道为什么，一直说我未授权

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2235145, encodeId=b60d22351454a, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：HHV8;Burkitt lymphoma;EBV<br>经验分享：编辑和审稿人都非常友好，投稿5周无回复，发邮件问了一下，1周后小修，之后4周顺利发表，前后用时12周左右，是我发表文章最顺利的一次，衷心感谢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=31938185260, createdName=ms9000001702333969, createdTime=Mon Nov 04 20:35:15 CST 2024, time=2024-11-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=894038, encodeId=6d2389403809, content=审稿速度:2.0 | 投稿命中率:95.0<br>经验分享：从投稿到接收2个月，中间两次大修, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24e71740290, createdName=changer11, createdTime=Fri Oct 23 23:55:35 CST 2020, time=2020-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2123578, encodeId=d41521235e840, content=投稿2个月了，还没找到审稿人，好慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f215550116, createdName=ms8000000387487195, createdTime=Mon Apr 03 23:17:10 CST 2023, time=2023-04-03, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1105501, encodeId=8fd8110550150, content=关键词最少几个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105502, encodeId=c8b2110550242, content=一般期刊要求关键词有多少个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601201, encodeId=2c11601201f3, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:2380.0<br>偏重的研究方向：病毒;肿瘤;感染<br>经验分享：编辑很友好，每次发邮件询问都很快回复，并及时将我的疑问转达给审稿人。审稿人很负责，认真回答我的问题。2月初投稿，4月28接收。大修1次，小修1次。现在proof。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220130/d287bef646804051826c653c20ade5c5/3189bee4394c4a70a2c21f4e2d6b8f13.jpg, createdBy=cb882558554, createdName=cmj544, createdTime=Tue Jun 02 17:50:51 CST 2020, time=2020-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574295, encodeId=e0d75e4295b2, content=还没投出去呢，不知道为什么，一直说我未授权, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIJiaCLWwZ60RaAUTVZeItKTcsUicNPFHRB64Bo60Rk8ICbaZCX5YcWrz5kgZqEH8UiaxuECuUufYmZg/132, createdBy=01cb2245548, createdName=呦呦517383645, createdTime=Thu Aug 01 22:01:00 CST 2019, time=2019-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846924, encodeId=40f584692407, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：比较一般的期刊吧，不过还是可以考虑一下的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c09a5414026, createdName=ms4662714744603927, createdTime=Mon Sep 03 15:50:22 CST 2018, time=2018-09-03, status=1, ipAttribution=)]
    2018-09-03 ms4662714744603927

    审稿速度:1.0 | 投稿命中率:25.0
    经验分享：比较一般的期刊吧，不过还是可以考虑一下的

    0

共13条页码: 1/2页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分

Baidu
Baidu
map
Baidu
map
Baidu
map